Cargando…

Radiographic Hepatic Steatosis Is Not Associated With Key Clinical Outcomes Among Patients Hospitalized With COVID-19

BACKGROUND: Metabolic syndrome increases adverse outcomes in coronavirus disease 2019 (COVID-19) infection. Hepatic steatosis may increase risk of COVID-19 severity. Current studies evaluating steatosis lack reliable definitions. We aimed to evaluate the association of radiographic hepatic steatosis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Trivedi, Hirsh D., Wilechansky, Robert, Goyes, Daniela, Vieira Barbosa, Joana, Canakis, Andrew, Lai, Michelle, Long, Michelle T., Fricker, Zachary
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elmer Press 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256898/ https://www.ncbi.nlm.nih.gov/pubmed/34267833 http://dx.doi.org/10.14740/gr1389

Ejemplares similares

Reduced steatosis and weight as a result of specific diets or the dietitian themselves
por: Trivedi, Hirsh D., et al.
Publicado: (2021)

Upper Gastrointestinal Bleeding: A Potential Precursor to Bouveret’s Syndrome
por: Goyes, Daniela, et al.
Publicado: (2021)

Osteoporosis in Primary Biliary Cholangitis: Prevalence, Impact and Management Challenges
por: Trivedi, Hirsh D, et al.
Publicado: (2020)

Waitlist Mortality and Posttransplant Outcomes in African Americans with Autoimmune Liver Diseases
por: Nsubuga, John Paul, et al.
Publicado: (2021)

Changes in human hepatic metabolism in steatosis and cirrhosis
por: Schofield, Zoe, et al.
Publicado: (2017)

Nonalcoholic Fatty Liver Disease Screening in Type 2 Diabetes Mellitus Patients in the Primary Care Setting
por: Vieira Barbosa, Joana, et al.
Publicado: (2020)

Strategies for a two-step liver fibrosis assessment in clinical practice
por: Vieira Barbosa, Joana, et al.
Publicado: (2021)

Race/Ethnicity Is Not Independently Associated with Risk of Adverse Waitlist Removal among Patients with HCC Exception Points
por: Goyes, Daniela, et al.
Publicado: (2021)

Adherence to Ideal Cardiovascular Health Metrics Is Associated With Reduced Odds of Hepatic Steatosis
por: DeCoste, Leah R., et al.
Publicado: (2020)

Hepatic Steatosis is Associated with Lower Levels of Physical Activity Measured via Accelerometry
por: Long, Michelle T., et al.
Publicado: (2015)

Steatosis and hepatitis C
por: Modaresi Esfeh, Jamak, et al.
Publicado: (2016)

Cancer and hepatic steatosis
por: Paternostro, R., et al.
Publicado: (2021)

Effect modification of hepatitis B viral load on the association between metabolic risk factors and hepatic steatosis
por: Shi, Michelle Y., et al.
Publicado: (2023)

Computed Tomography Measurement of Hepatic Steatosis: Prevalence of Hepatic Steatosis in a Canadian Population
por: Wells, Malcolm M., et al.
Publicado: (2016)

Management of Primary Biliary Cholangitis: Current Treatment and Future Perspectives
por: Barba Bernal, Romelia, et al.
Publicado: (2023)

Inflammatory Mediators of Hepatic Steatosis
por: Hijona, Elizabeth, et al.
Publicado: (2010)

Effect of Vildagliptin on Hepatic Steatosis
por: Macauley, Mavin, et al.
Publicado: (2015)

Hepatic steatosis in patients with acromegaly
por: Koutsou‐Tassopoulou, Andreani, et al.
Publicado: (2019)

Hepatic glucose utilization in hepatic steatosis and obesity
por: Keramida, Georgia, et al.
Publicado: (2016)

Heptadecanoic Acid Is Not a Key Mediator in the Prevention of Diet-Induced Hepatic Steatosis and Insulin Resistance in Mice
por: Bishop, Christopher A., et al.
Publicado: (2023)

The impact of hepatic steatosis on portal hypertension
por: Semmler, Georg, et al.
Publicado: (2019)

Hepatic Fibrosis and Steatosis in Metabolic Syndrome
por: Gangireddy, Venu Gopala Reddy, et al.
Publicado: (2022)

Endoscopic treatment of a hepatic cyst, buried lumen-apposing metal stent, and liver abscess: the good, the bad, the ugly
por: Canakis, Andrew, et al.
Publicado: (2023)

Hepatitis C Virus (HCV) Infection and Hepatic Steatosis
por: Yoon, Eugene J., et al.
Publicado: (2006)

Hemodynamic changes in hepatic sinusoids of hepatic steatosis mice
por: Fan, Jing, et al.
Publicado: (2019)

Assessment of Predictive Factors of Hepatic Steatosis Diagnosed by Vibration Controlled Transient Elastography (VCTE) in Chronic Hepatitis C Virus-Infected Patients
por: Singh, Yuvaraj, et al.
Publicado: (2022)

Hepatic Glucose Intolerance Precedes Hepatic Steatosis in the Male Aromatase Knockout (ArKO) Mouse
por: Van Sinderen, Michelle L., et al.
Publicado: (2014)

Cathelicidin suppresses lipid accumulation and hepatic steatosis by inhibition of the CD36 receptor
por: Tran, Deanna Hoang-Yen, et al.
Publicado: (2016)

Morphometric Analysis of Hepatic Steatosis in Chronic Hepatitis C Infection
por: Zubair, Alia, et al.
Publicado: (2009)

Hepatic steatosis is highly prevalent but is not correlated with stiffness in autoimmune hepatitis
por: Chalasani, Sai, et al.
Publicado: (2020)

Multiple hepatic pseudotumors: A rare presentation of hepatic steatosis
por: Fujikawa, Hirohisa, et al.
Publicado: (2020)

Hepatic deficiency of selenoprotein S exacerbates hepatic steatosis and insulin resistance
por: Qiao, Lu, et al.
Publicado: (2022)

Insulin resistance, steatosis and hepatitis C virus
por: Mangia, Alessandra, et al.
Publicado: (2013)

Hepatic Steatosis as a Marker of Metabolic Dysfunction
por: Fabbrini, Elisa, et al.
Publicado: (2015)

Melatonin: a potential intervention for hepatic steatosis
por: Sun, Hang, et al.
Publicado: (2015)

Hepatitis C Virus, Insulin Resistance, and Steatosis
por: Kralj, Dominik, et al.
Publicado: (2016)

Hepatic steatosis and fibrosis: Non-invasive assessment
por: Karanjia, Rustam N, et al.
Publicado: (2016)

Role of glycoprotein 78 and cidec in hepatic steatosis
por: Li, Jie, et al.
Publicado: (2017)

Hepatocellular Carcinoma in a Patient With Hepatic Steatosis
por: Romano, John, et al.
Publicado: (2020)

Role of PAI-1 in hepatic steatosis and dyslipidemia
por: Levine, Joshua A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v4jhe0pamt2kl2br71s45h14as